Brendan Teehan Pacira Bio Sciences, Inc. (PCRX) insider trading activity

PCRX Quotes by TradingView

Brendan Teehan is Chief Commercial Officer of Pacira BioSciences, Inc.. Currently has a direct ownership of 54,402 shares of PCRX, which is worth approximately $1.29 Million. The most recent transaction as insider was on Dec 31, 2025, when has been sold 402 shares (Common Stock) at a price of $10.76 per share, resulting in proceeds of $4,325. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54.4K
0.74% 3M change
n/a 12M change
Total Value Held $1.29 Million

Brendan Teehan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2025
BUY
Grant, award, or other acquisition
$4,325 $10.76 p/Share
402 Added 0.73%
54,402 Common Stock
Feb 01 2025
BUY
Grant, award, or other acquisition
-
54,000 Added 50.0%
54,000 Common Stock

Also insider at

ACAD
ACADIA PHARMACEUTICALS INC Healthcare
EVP, COO, HEAD OF COMMERCIAL
BT

Brendan Teehan

Chief Commercial Officer
San Diego, CA

Track Institutional and Insider Activities on PCRX

Follow Pacira BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

News

Receive news related to Pacira BioSciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCRX